• About
    • Mission
    • Leadership
    • Careers
    • Clinical Advisory Board
    • News
    • Media & Press
    • Events
  • Viveve Solutions
    • Viveve System
    • InControl
  • Healthcare Providers
    • Clinical Studies
    • Become a Provider
    • Manage Your Listing
    • Hub Login
    • FAQs
    • Product Feedback
  • Patients
    • Blog
    • Find A Provider
    • Refer A Provider
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • FAQs
    • Viveve Hub
    • Submit a Product Experience
  • Product Indication
Select Page
Viveve | US

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Publications
    • IR Calendar
    • Analyst Coverage
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Clinical Advisory Board
    • Medical Consultants
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Investor Presentation
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Publications
  • IR Calendar
  • Analyst Coverage
  • Email Alerts

Viveve Launches GENEVEVE™ by Viveve Treatment in Canada

Oct 30, 2017

Viveve Releases Preliminary Third Quarter 2017 Financial Results

Oct 18, 2017

Viveve Announces Regulatory Approval for Viveve System in Mexico

Oct 17, 2017

Viveve Announces Regulatory Approval for Viveve System in Taiwan

Oct 10, 2017

Viveve to Present at the Ladenburg Thalmann 2017 Healthcare Conference

Sep 19, 2017

Viveve Announces Additional Regulatory Approvals in Middle East

Sep 12, 2017

Viveve to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

Sep 5, 2017

Viveve Announces Second Quarter 2017 Financial Results and Strategic Partnership with InControl Medical, LLC

Aug 10, 2017

Viveve to Announce Second Quarter 2017 Financial Highlights

Aug 3, 2017

Viveve Selected for Inclusion in Russell 2000(R) Index

Jun 27, 2017
RSS
    • 1...
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • ...31

    Viveve

    A Global Women’s Intimate Health Company

    Terms of Use | Privacy Policy
    © 2021 Viveve Solutions. All Rights Reserved.

    • About
    • Viveve Solutions
    • Providers
    • Patients
    • Investors
    • Careers
    • Contact Us



    • Hub Login
    • Product Feedback

    345 Inverness Drive South
    Building B, Suite 250
    Englewood, CO 80112

    The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.

    The Viveve® System is an internationally patented cryogen-cooled monopolar radiofrequency (CMRF) energy-based platform device. It has received regulatory approvals and clearances in many countries throughout the world and is available through physician import license in Japan and China. In the United States the Viveve System is cleared by the FDA for general surgery procedures for electrocoagulation and hemostasis. International approvals and clearances include vaginal laxity and/or improvement of sexual function indications. In Argentina improvement of urinary incontinence in women is also an approved indication.

    Translate »